Detalles de la búsqueda
1.
JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.
Cancer
; 128(1): 65-74, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478166
2.
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor.
Future Oncol
; 18(11): 1333-1342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144482
3.
Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials.
Cancer
; 124(9): 2010-2017, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29469949
4.
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.
Lancet Oncol
; 18(5): 599-610, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373005
5.
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(3): 367-377, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26874901
6.
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.
Clin Cancer Res
; 30(1): 74-81, 2024 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535056
7.
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.
Breast Cancer Res Treat
; 140(2): 341-51, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23877339
8.
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.
Cancer Res Commun
; 3(12): 2572-2584, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38115208
9.
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
J Immunother Cancer
; 8(2)2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907924
10.
Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.
Cancer Res Commun
; 4(3): 785, 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477691
11.
Construction of a drug safety assurance information system based on clinical genotyping.
ISRN Bioinform
; 2012: 982737, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-25969745
12.
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.
Clin Lung Cancer
; 13(1): 31-8, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21862415
13.
Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy.
J Thorac Oncol
; 7(6): 1041-8, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22534814
14.
The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or Irinotecan in second-line therapy for metastatic colorectal cancer: the secondary analysis from STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS status.
Clin Colorectal Cancer
; 10(4): 333-9, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22000810
15.
Pharmacogenomics training using an instructional software system.
Am J Pharm Educ
; 75(2): 32, 2011 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21519421
16.
Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer.
J Clin Oncol
; 28(8): 1351-7, 2010 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20142600
17.
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.
J Clin Oncol
; 28(6): 911-7, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20100966
18.
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
J Clin Oncol
; 26(19): 3213-21, 2008 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18591556
Resultados
1 -
18
de 18
1
Próxima >
>>